Part-Time
Nurse Practitioner
Midi
501-1,000 employees
Virtual menopause care platform with insurance coverage
Compensation Overview
$60 - $70/hr
No H1B Sponsorship
Remote in USA
Remote
Remote position based in the United States; patient-local scheduling between 7:00 AM and 7:00 PM; Washington State residency required.
 Medical, Clinical & Veterinary (1) |
|---|
- Residency in Washington State required for duration of employment.
- Active, unrestricted, and unencumbered Nurse Practitioner license in at least one U.S. state.
- Multiple state licenses highly preferred.
- Prescriptive authority as a Nurse Practitioner.
- Active national board certifications as a Nurse Practitioner (Family Nurse Practitioner, Women's Health Nurse Practitioner, Adult-Gerontology Nurse Practitioner, or similar).
- Minimum of 3 years of recent experience (within the last 5 years) practicing as a Nurse Practitioner in Primary Care, Women’s Health, or Gynecology.
- Ability to work independently and make sound clinical decisions.
- High level of proficiency and efficiency with technology (telehealth, electronic medical records, communication tools).
- A strong, demonstrated passion for caring for women navigating menopause and midlife health transitions.
- Guide women through perimenopause, menopause, and other midlife transitions with compassionate, evidence-based care.
- Provide remote, patient-facing care within a virtual-first care model.
- Conduct structured, high-quality visits with appropriate time for education and personalization.
- Follow evidence-based clinical pathways that combine hormonal therapy, lifestyle coaching, and medication when appropriate.
- Order and review labs, provide prescriptions, and make referrals as needed through the platform.
- Collaborate with a multidisciplinary care team including care coordinators and clinical leaders; participate in ongoing clinical education and professional development.
- Maintain patient continuity and scheduling within the defined part-time structure and time blocks.
Midi Health runs a nationwide virtual clinic for midlife women's health focused on perimenopause and menopause. It uses evidence-based clinical protocols trained for nurse practitioners and physicians to deliver care at scale, and it contracts with major insurers to cover consultations, medications, and testing. The platform provides personalized care plans, hormone and non-hormonal treatments, testing, mental health and sexual wellness support, lifestyle coaching, and AgeWell preventive longevity, plus broader midlife health like cardiovascular risk, sleep, cancer screening adherence, and weight management. Its goal is to improve health outcomes for midlife women, reduce total cost of care, and make menopause and midlife health a standard part of preventive care and employee wellness.
Company Size
501-1,000
Company Stage
Series D
Total Funding
$262.9M
Headquarters
Los Altos, California
Founded
2021
Simplify's Take
What believers are saying
- Documented 28-point increase in breast cancer screening adherence among patient populations.
- Strategic partnerships with Mount Sinai, Stanford, Google Ventures validate clinical model.
- AgeWell supplement line and longevity programs expand revenue beyond HRT prescriptions.
What critics are saying
- FDA scrutiny of supplement claims for cognitive support and metabolic health triggers recalls.
- Insurance carriers impose stricter HRT prior authorizations, reducing reimbursement rates 20–30%.
- Direct-to-consumer competitors undercut insurance model, capturing 15–20% of weekly patients.
What makes Midi unique
- Insurance-reimbursed virtual menopause care across all 50 states, eliminating direct-pay barriers.
- Evidence-based clinical protocols led by world-renowned menopause experts, trained at scale.
- Holistic midlife health platform addressing cardiovascular, metabolic, cognitive, and cancer survivorship concerns.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 1%100,000 women in extreme pain. The top stories in women's health so far this week cover how a shingles shot is linked to lower dementia risk, rethinking when breast cancer screening should begin, and long-overdue data confirming thousands of women experience significant pain during C-sections every year. Feeling off lately? It could be your hormones. Allara helps women understand the root cause of their hormonal or metabolic symptoms with a comprehensive care team that combines expert medical and nutrition guidance. Whether you're managing PCOS, fertility challenges, perimenopause, thyroid conditions, or unexplained symptoms, you'll get a personalized care plan backed by advanced diagnostic testing and ongoing support. This isn't about quick fixes. It's about getting clarity and feeling like yourself again, with care that's accessible virtually and covered by insurance. A SHOT TO PREVENT DEMENTIA? // A study released early from Nature found people over age 65 who got the shingles vaccine were 51% less likely to develop dementia, and the "risk reduction was stronger in females compared to males." A drop in dementia risk is especially meaningful for women, who make up two thirds of Alzheimer's patients. ONE SIZE DOES NOT FIT ALL FOR BREAST CANCER SCREENINGS // The Washington Post's Leana Wen breaks down the latest findings on breast cancer screenings, and how experts are rethinking mammograms as the first step in the process. She explains how a recent study found genetic testing at 30 might catch more real risks and fewer false alarms. C-SECTION ANESTHESIA FAILURES // The New York Times "Daily" podcast revisits a series from last year on how anesthesia is failing some women during C-section surgery, causing extreme pain. The issue is finally getting studied, and a major study last month found about 8% of women endure significant pain during a C-section. And with 1.2 million C-sections in the US every year, that means "100,000 women a year experience significant pain." MARY CLAIRE HAVER JOINS MIDI // Midi Health has hired the original Instagram menopause expert, Dr. Mary Claire Haver, as its first "Chief AgeWell Officer." CEO Joanna Strober said in a press release that "by collaborating with Dr. Haver, we are ensuring women continue to have access to care designed for their bodies, their hormones, and their real lives." MIDWIFES FOR MENOPAUSE // Ms. Magazine has an essay from a fourth-generation midwife reviving an old truth: midwifery isn't just for birth, it has also covered menopause (and still can). Racha Tahani Lawler describes her practice of offering individualized care that keeps bodily autonomy in the hands of patients.
Midi Health, a virtual care clinic for women, has appointed Dr Mary Claire Haver as its first Chief AgeWell Officer. Dr Haver, a board-certified obstetrician-gynaecologist and Menopause Society Certified Practitioner, will work with Midi's clinical team to develop a proactive health model integrating menopause management with metabolic health, bone density, brain health and cardiovascular risk assessment. The platform focuses on preventative care targeting primary causes of female mortality and disability: heart disease, bone loss and cognitive decline. Dr Haver, founder of The Pause Life and author of bestselling books on midlife health, brings extensive experience in women's healthcare and medical education. Midi Health provides insurance-covered telehealth services across all 50 US states, positioning itself as the fastest-growing women's telehealth company in the nation.
Midi Health, the fastest growing women’s telehealth company, today announced it raised $100 million in a Series D financing round.
Midi Health has raised $50 million in Series C funding led by Advance Venture Partners, bringing total funding to approximately $150 million, Business Insider reported. The round closed in spring 2025. The virtual menopause and perimenopause care company now serves 20,000 patients weekly, roughly double its patient base from January 2025. CEO Joanna Strober shared
Midi Health, a women's health startup focused on menopause care, has raised $50 million in Series C funding. The company, led by CEO Joanna Strober, has achieved a $150 million run rate and serves 20,000 patients weekly.